Deeply oversold status limits further downside for Injective drop

Traders Union
All News
Crypto
Injective drops 7.14% today to $4.58

Highlights

Injective's Vulcan upgrade slashes oracle gas costs by 90% and enables institutional-grade price feeds for EVM smart contracts.
Expanded integration with Pyth Pro and SEDA aims to attract developers and institutional users despite weak recent price performance.
Technicals are strongly bearish, with INJ trading below key averages and likely to remain in the $4.18–$4.79 range short-term.

Developer access broadens as Vulcan upgrade slashes costs and adds feeds

Injective has implemented its Vulcan upgrade, reducing oracle gas costs by 90% and adding integration with Pyth Pro and SEDA to broaden EVM developer access on its Layer 1 network, according to Cryptobriefing. This upgrade introduces institutional-grade price feeds to EVM smart contracts on Injective, which may improve the platform's appeal to developers and larger market participants by lowering operating costs and increasing technical capabilities. The move follows earlier upgrades and reflects ongoing infrastructure improvements, though price action has remained under broader selling pressure.

Support holds while oversold signals and strong momentum drive bears

INJ is trading below the MA-20 level at $4.76 and the MA-50 at $4.87, while holding above the MA-200, which sits at $4.17. Immediate resistance is marked by the Ichimoku Kijun at $4.78. Both the MACD and ADX indicate continued selling momentum, while deeply oversold readings are registered on the RSI (25.87), Stoch RSI, and CCI. Bull/Bear Power (BBP) highlights dominant intraday selling, and the Awesome Oscillator supports the established downtrend.

Sideways trading likely as bearish risk outweighs rebound chances

Over the next 2–3 trading days, INJ is expected to fluctuate within a $4.18–$4.79 volatility band relative to current levels. The probability of an upward move is considered very low, while downward risk is elevated. The baseline expectation is for sideways price movement; significant bullish action would require a breakout above immediate resistance, while a drop below $4.18 would trigger a new bearish scenario.

Anton Kharitonov, expert at Traders Union, sees INJ price action as decisively weak despite the positive network developments from the Vulcan upgrade. He notes that downward momentum persists, with the asset trading below short- and medium-term moving averages and no clear reversal signs from key technical indicators. The analyst remains cautious as significant selling pressure and oversold readings continue to dominate. "Until INJ can reclaim resistance above $4.78, I see no tactical reason to expect any meaningful recovery here."

Earlier, analysts noted that Injective was exhibiting mixed momentum signals, reflecting an uncertain price direction amid both short-term weakness and attempts to stabilize. Reinforced by the recent technical breakdown and persistent selling pressure despite ongoing network upgrades, traders should remain alert to elevated downside risk and monitor for a decisive move below the $4.18 support as a signal of further bearish continuation.

Source of Data: INJ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.